Mangrove Partners Ocular Therapeutix, Inc Transaction History
Mangrove Partners
- $769 Million
- Q3 2024
A detailed history of Mangrove Partners transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Mangrove Partners holds 21,416 shares of OCUL stock, worth $178,823. This represents 0.02% of its overall portfolio holdings.
Number of Shares
21,416Holding current value
$178,823% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding OCUL
# of Institutions
171Shares Held
138MCall Options Held
150KPut Options Held
225K-
Summer Road LLC West Palm Beach, FL14.4MShares$120 Million98.8% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$107 Million11.5% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$106 Million4.08% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$96.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$70 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $643M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...